The Molecular Diagnostics (MDx) Market will reach $10.45bn in 2019 predicts new visiongain reportBy: Visiongain A new report by visiongain predicts that the global Molecular Diagnostics (MDx) market will reach $10.45bn in 2019. This forecast and others appear in The Molecular Diagnostics (MDx) Market Forecast 2015-2025: Opportunities for Leading Companies, published in October 2015. Visiongain is a business information provider based in London, UK. The Molecular Diagnostics (MDx) Market Forecast 2015-2025: Opportunities for Leading Companies report examines the current and future trends in the molecular diagnostic segment of the in vitro diagnostic market. Molecular diagnostic techniques offer a whole range of advantages over traditional methods for diagnosing disease, with higher accuracy, improved specificity and lower turnaround times, it is more possible than ever to turn a sample into pertinent clinical information in a matter of hours. With reports indicating that in vitro diagnostics influence up to 60% of clinical decision making, an understanding of the molecular diagnostics market and the technologies available is crucial for all those in fields related to the sector. In this report, we examine in detail a number of key national markets, as well as the sales of a wide range of leading diagnostic assays and automation instruments in the following submarkets: infectious disease testing, oncology testing, blood screening, genetic testing and tissue typing. Using both primary and secondary research, forecasts have been built for both national markets and diagnostic targets, accompanied by text giving a thorough explanation of events thought to shape the market currently and in the future. Also included is analysis of the current leading players in the Molecular Diagnostics (MDx) market. This includes a look at their current products, as well those presently in development. Recent financial performance is analysed, along with a breakdown of each company’s leading products and recent merger & acquisition information, with an analysis of news that may influence the course of the company. Matteo Bianchi, a pharmaceutical and medical devices industry analyst in visiongain, said: “Molecular diagnostic techniques offer a large set of advantages over traditional diagnostic methods. They have the capability to detect diseases earlier than ever before thanks to the ability to amplify very low levels of viral and bacterial DNA. Recent advances have led to certain tests becoming so quick and easy to use that an untrained person can obtain significant clinical results in a matter of minutes, something which is essential in resource limited settings. Next-generation sequencing techniques also have the potential to be game changing for the way we understand the genetic origin of disease. All these factors combined with a relatively immature market allows for serious potential for growth in the next 10 years.” Visiongain’s report provides revenue forecasts to 2025 for the Molecular Diagnostic market and its leading national markets. The report discusses selected leading companies which hold significant shares of the market. These companies include Roche Diagnostics, Qiagen, Hologic, Becton Dickinson & Company., bioMérieux, Cepheid, Agilent Technologies. An exclusive interview with a Qiagen executive is provided in full. Visiongain’s report also discusses key economic points, commercial news, and analysis of strengths, weaknesses, opportunities and threats. The Molecular Diagnostics (MDx) Market Forecast 2015-2025: Opportunities for Leading Companies adds to visiongain’s range of analytical reports on industries and markets in healthcare. For an executive summary please contact: Email: Sara Peerun on sara.peerun@ Tel: +44 (0) 20 7336 6100 Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@ About visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors. Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions. End
|
|
